T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites

Blood - Tập 101 - Trang 2300-2306 - 2003
Shigeto Yoshida, Tominari Kobayashi, Hiroyuki Matsuoka, Chisato Seki, William L. Gosnell, Sandra P. Chang, Akira Ishii

Tóm tắt

A novel bispecific single-chain antibody fragment (biscFv) has been constructed to address the possibility of a new approach to malaria therapeutic drug development. The biscFv consists of 2 different single-chain antibody fragments linked by a flexible peptide linker (Gly4-Ser)3. Of the 2 scFv fragments, one is directed against a conserved epitope of the 19-kDa C-terminal fragment of the major surface protein of human malignant malaria parasite, Plasmodium falciparum, and the other is directed against the CD3 antigen of human T cells. The biscFv expressed by a recombinant baculovirus retained the antigen-binding properties of the corresponding univalent single-chain antibody fragments and formed a bridge between P falciparum and T cells. In cooperation with T cells, the biscFv specifically induced not only interferon γ and tumor necrosis factor α, but also a significant increase of merozoite phagocytosis and growth inhibition of P falciparum in vitro. Thus, the biscFv possesses highly selective malaria-targeting properties and stimulates T cells to induce cytokines, presumably resulting in activation of macrophages, neutrophils, and natural killer cells, and parasite killing in vivo.

Tài liệu tham khảo

World Health Organization, 1998, The World Health Report 1998. Life in the 21st century: a vision for all. Mack, 1995, A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity., Proc Natl Acad Sci U S A., 92, 7021, 10.1073/pnas.92.15.7021 Loffler, 2000, A recombinant bispecific single-chain antibody, CD19 × CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes., Blood., 95, 2098, 10.1182/blood.V95.6.2098 Belani, 1995, T cell activation and cytokine production in anti-CD3 bispecific antibody therapy., J Hematother., 4, 395, 10.1089/scd.1.1995.4.395 George, 1994, Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule., J Immunol., 152, 1802, 10.4049/jimmunol.152.4.1802 Barth, 2000, Ki-4(scFv)-ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice., Blood., 95, 3909, 10.1182/blood.V95.12.3909 Tibben, 1996, Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab′)2 in ovarian carcinoma patients., Int J Cancer., 66, 477, 10.1002/(SICI)1097-0215(19960516)66:4<477::AID-IJC11>3.0.CO;2-5 Canevari, 1995, Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody., J Natl Cancer Inst., 87, 1463, 10.1093/jnci/87.19.1463 De Gast, 1995, CD8 T cell activation after intravenous administration of CD3 × CD19 bispecific antibody in patients with non-Hodgkin lymphoma., Cancer Immunol Immunother., 40, 390, 10.1007/BF01525390 Chamow, 1995, A humanized, bispecific immunoadhesin-antibody that retargets CD3+ effectors to kill HIV-1-infected cells., J Hematother., 4, 439, 10.1089/scd.1.1995.4.439 Traunecker, 1991, Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells., EMBO J., 10, 3655, 10.1002/j.1460-2075.1991.tb04932.x Berg, 1991, Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain., Proc Natl Acad Sci U S A., 88, 4723, 10.1073/pnas.88.11.4723 Chappel, 1993, Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1., Mol Biochem Parasitol., 60, 303, 10.1016/0166-6851(93)90141-J Kumar, 1995, Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys., Mol Med., 1, 325, 10.1007/BF03401557 Hirunpetcharat, 1997, Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells., J Immunol., 159, 3400, 10.4049/jimmunol.159.7.3400 Keitel, 1999, Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid., Vaccine., 18, 531, 10.1016/S0264-410X(99)00221-2 Yoshida, 1999, A single-chain antibody fragment specific for the Plasmodium berghei ookinete protein Pbs21 confers transmission blockade in the mosquito midgut., Mol Biochem Parasitol., 104, 195, 10.1016/S0166-6851(99)00158-9 Trager, 1976, Human malaria parasites in continuous culture., Science., 193, 673, 10.1126/science.781840 Arakawa, 1996, Cloning and sequencing of the VH and V kappa genes of an anti-CD3 monoclonal antibody, and construction of a mouse/human chimeric antibody., J Biochem., 120, 657, 10.1093/oxfordjournals.jbchem.a021462 Chang, 1992, A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth., J Immunol., 149, 548, 10.4049/jimmunol.149.2.548 Julius, 1973, A rapid method for the isolation of functional thymus-derived murine lymphocytes., Eur J Immunol., 3, 645, 10.1002/eji.1830031011 Salmon, 2001, Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis., Proc Natl Acad Sci U S A., 98, 271, 10.1073/pnas.98.1.271 Lambros, 1976, Synchronization of P. falciparum eythrocytic stages in culture., J Parasitol., 65, 418, 10.2307/3280287 Bouharoun-Tayoun, 1990, Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes., J Exp Med., 172, 1633, 10.1084/jem.172.6.1633 Chang, 1994, Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype., J Immunol., 152, 3483, 10.4049/jimmunol.152.7.3483 Gur, 1992, Modulatory effect of aggregating the CD3 molecular complex on T cell activation., Cell Immunol., 140, 81, 10.1016/0008-8749(92)90178-R Tsygankov, 1992, Inhibition of the anti-CD3-induced T cell proliferation by crosslinking of stimulatory antibodies in the presence of PMA and interleukin-2., Cell Immunol., 140, 97, 10.1016/0008-8749(92)90179-S Kwiatkowski, 1989, Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture., Clin Exp Immunol., 77, 361 Peyron, 1990, Plasma levels of tumor necrosis factor during a longitudinal survey in an endemic area of malaria., Acta Trop., 47, 47, 10.1016/0001-706X(90)90006-L Kumaratilake, 1994, T-cell cytokines in malaria: their role in the regulation of neutrophil- and macrophage-mediated killing of Plasmodium falciparum asexual blood forms., Res Immunol., 145, 423, 10.1016/S0923-2494(94)80172-X Jensen, 1989, Malaria crisis forms: intraerythrocytic development derangement. In M. M. Stevenson, ed., Malaria: Host Reponses to Infection., 109 Bouharoun-Tayoun, 1995, Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages., J Exp Med., 182, 409, 10.1084/jem.182.2.409 Kufer, 2001, Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructs., Cancer Immun., 1, 10